{
    "title": "AstraZeneca bets up to $6 billion on new Daiichi cancer drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8563575/AstraZeneca-signs-6-bln-cancer-drug-deal-Daiichi.html",
    "date": "2020-07-27",
    "keywords": [
        "cancer",
        "drug",
        "breast",
        "astrazeneca",
        "ds1062",
        "deal",
        "lung",
        "protein",
        "pushkala",
        "aripaka",
        "oncology",
        "type",
        "drugmaker",
        "coronavirus",
        "vaccine",
        "trop2",
        "cell",
        "group",
        "year",
        "adc",
        "baselga",
        "approval",
        "use",
        "reporting",
        "july",
        "sankyo",
        "multibillion",
        "dollar",
        "collaboration",
        "market",
        "treatment",
        "portfolio",
        "area",
        "focus",
        "company",
        "candidate",
        "monday",
        "class",
        "forecast",
        "potential",
        "conjugate",
        "executive",
        "soriot",
        "number",
        "blockbuster",
        "revenue",
        "jp",
        "morgan",
        "astrazenecas",
        "dividend",
        "indebtedness",
        "ability",
        "her2",
        "gmt",
        "stock",
        "phase",
        "trial",
        "role",
        "compound",
        "jose",
        "head",
        "research",
        "request",
        "category",
        "chemotherapy",
        "antitrop2",
        "trodelvy",
        "april",
        "biothera",
        "biotech",
        "boost",
        "unit",
        "onmarket",
        "blood",
        "europe",
        "supply",
        "companys",
        "japan",
        "jagadeesh",
        "babu",
        "burger",
        "frankfurt",
        "editing",
        "saumyadeb",
        "chakrabartydavid",
        "holmesjane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}